Funder
the Project of the National Natural Science Funding of China
the Special Fund for Research in the Public Interest from the National Health and Family Planning Commission of PRC
Key Lab System Project of Guangdong Science and Technology Department–Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer
Research Funds from the Guangzhou Science and Technology Bureau
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference46 articles.
1. Li TH, Kung HJ, Mack PC, Gandara DR. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol. 2013;31(8):1039–49.
2. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–6.
3. Horn L, Pao W. EML4-ALK: honing in on a new target in non-small-cell lung cancer. J Clin Oncol. 2009;27(26):4232–5.
4. Shaw AT, Yeap BY, Mino-Kenudson M, Digumarthy SR, Costa DB, Heist RS, et al. Clinical features and outcome of patients with non–small-cell lung Cancer who harbor EML4-ALK. J Clin Oncol. 2009;27(26):4247–53.
5. Zhang XC, Lu S, Zhang L, Wang CL, Cheng Y, Li GD, et al. Consensus on dignosis for ALK positive non-small cell lung cancer in China, the 2013 version. Zhonghua Bing Li Xue Za Zhi. 2013;42(6):402–6.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献